157 related articles for article (PubMed ID: 30766891)
21. The Effect of Entecavir Therapy on Immune Status in Chronic Hepatitis B Patients.
Yan H; Zhang X; Lv Y
Iran J Immunol; 2019 Mar; 16(1):84-91. PubMed ID: 30864558
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis.
Liu F; Wang X; Wei F; Hu H; Zhang D; Hu P; Ren H
Virol J; 2014 Mar; 11():59. PubMed ID: 24673792
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir.
Choi HN; Song JE; Lee HC; Jo HH; Lee CH; Kim BS
Clin Mol Hepatol; 2015 Mar; 21(1):24-31. PubMed ID: 25834799
[TBL] [Abstract][Full Text] [Related]
24. Antiviral efficacy of entecavir versus entecavir plus adefovir for hepatitis B virus rtA181V/T mutants alone.
Oh MJ; Lee HJ
Saudi J Gastroenterol; 2016; 22(1):37-42. PubMed ID: 26831605
[TBL] [Abstract][Full Text] [Related]
25. Prolonged entecavir therapy is not effective for HBeAg seroconversion in treatment-naive chronic hepatitis B patients with a partial virological response.
Lee HW; Kwon JC; Oh IS; Chang HY; Cha YJ; Choi IS; Kim HJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5348-56. PubMed ID: 26100697
[TBL] [Abstract][Full Text] [Related]
26. Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir.
Gish RG; Chang TT; Lai CL; de Man RA; Gadano A; Llamoso C; Tang H
Antivir Ther; 2013; 18(5):691-8. PubMed ID: 23510982
[TBL] [Abstract][Full Text] [Related]
27. Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir.
Lu L; Yip B; Trinh H; Pan CQ; Han SH; Wong CC; Li J; Chan S; Krishnan G; Wong CC; Nguyen MH
J Viral Hepat; 2015 Aug; 22(8):675-81. PubMed ID: 25417914
[TBL] [Abstract][Full Text] [Related]
28. Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: a randomised open-label trial (OSST trial).
Ning Q; Han M; Sun Y; Jiang J; Tan D; Hou J; Tang H; Sheng J; Zhao M
J Hepatol; 2014 Oct; 61(4):777-84. PubMed ID: 24915612
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of HBV-pulsed DCs in combination with entecavir in patients with chronic hepatitis B infection.
Wei MJ; Pan XN; Wei KP; Li XH; Liu XL; Zhang XM; Jiang YL; Zhang CY; Shen JK
Int Immunopharmacol; 2015 Aug; 27(2):238-43. PubMed ID: 26118632
[TBL] [Abstract][Full Text] [Related]
30. Beneficial therapeutic effect of Chinese herbal Bushen formula on CHB patients with mildly elevated alanine aminotransferase by down-regulating CD4+CD25+T cells.
Li M; Sun XH; Zhou ZH; Yu Z; Jin SG; Zhu XJ; Gao YQ
J Ethnopharmacol; 2013 Mar; 146(2):614-22. PubMed ID: 23395622
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of addition of Tenofovir Disoproxil Fumarate to Peg-IFNα-2b is superior to the addition of Entecavir in HBeAg positive CHB patients with a poor response after 12 weeks of Peg-IFNα-2b treatment alone.
Lin S; Fu Y; Wu W; Chen T; Chen N; Xun Z; Liu C; Ou Q; Zeng Y; Huang H
Int J Med Sci; 2020; 17(10):1458-1463. PubMed ID: 32624702
[No Abstract] [Full Text] [Related]
32. Comparison of fibrosis regression of entecavir alone or combined with pegylated interferon alpha2a in patients with chronic hepatitis B.
Chen S; Zhou J; Wu X; Meng T; Wang B; Liu H; Wang T; Zhao X; Kong Y; Wu S; Ou X; Jia J; Sun Y; You H
Hepatol Int; 2021 Jun; 15(3):611-620. PubMed ID: 33677771
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir.
Kuo MT; Hu TH; Hung CH; Wang JH; Lu SN; Tsai KL; Chen CH
Aliment Pharmacol Ther; 2019 Jan; 49(2):218-228. PubMed ID: 30484881
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Serum IFN- and IL-5 Levels in Response to Entecavir Therapy in Patients with Chronic Hepatitis B Virus Infection.
Badary TM; ElBadawy O; Agban MN; Kamel S; Sadek A
Egypt J Immunol; 2018 Jan; 25(1):93-103. PubMed ID: 30243001
[TBL] [Abstract][Full Text] [Related]
35. Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial.
Li X; Zhou D; Chi X; Li Q; Wang L; Lu B; Mao D; Wu Q; Wang X; Zhang M; Xue J; Li Y; Lu W; Guo J; Jiang F; Zhang X; Li Z; Yang X; Guo H; Gan D; He L; Luo L; Zhang L; Du H; Ye Y
Hepatol Int; 2020 Dec; 14(6):985-996. PubMed ID: 33128206
[TBL] [Abstract][Full Text] [Related]
36. Serological and virological response in patients with hepatitis B virus genotype E treated with entecavir or tenofovir: a prospective study.
Boglione L; De Benedetto I; Lupia T; Cusato J; Cariti G; Di Perri G
Arch Virol; 2021 Apr; 166(4):1125-1131. PubMed ID: 33580380
[TBL] [Abstract][Full Text] [Related]
37. Long-term impact of entecavir monotherapy in chronic hepatitis B patients with a partial virologic response to entecavir therapy.
Ko SY; Choe WH; Kwon SY; Kim JH; Seo JW; Kim KH; Lee CH
Scand J Gastroenterol; 2012 Nov; 47(11):1362-7. PubMed ID: 22934534
[TBL] [Abstract][Full Text] [Related]
38. [Association of baseline alanine aminotransferase levels with therapeutic effects of entecavir and interferon-
Xiao Z; Zhou F; Zhou B; Yang J
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):150-155. PubMed ID: 30890501
[TBL] [Abstract][Full Text] [Related]
39. Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E.
Boglione L; Cardellino CS; De Nicolò A; Cariti G; Di Perri G; D'Avolio A
J Med Virol; 2014 Nov; 86(11):1845-50. PubMed ID: 25131947
[TBL] [Abstract][Full Text] [Related]
40. [HBeAg seroconversion achieved by sequential peginterferon alfa-2a therapy in chronic hepatitis B patients with unsatisfactory end point following entecavir treatment].
Chen XF; Chen XP; Ma XJ; Chen WL; Luo XD; Liao JY
Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):502-5. PubMed ID: 24074707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
